Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| 1 |
Tesla
TSLA
|
+$789M |
| 2 |
Apple
AAPL
|
+$641M |
| 3 |
Enbridge
ENB
|
+$596M |
| 4 |
Microsoft
MSFT
|
+$585M |
| 5 |
Amazon
AMZN
|
+$523M |
Top Sells
| 1 |
Alibaba
BABA
|
+$389M |
| 2 |
Toronto Dominion Bank
TD
|
+$384M |
| 3 |
Royal Bank of Canada
RY
|
+$327M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$296M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$260M |
Sector Composition
| 1 | Financials | 24.6% |
| 2 | Technology | 16% |
| 3 | Industrials | 8.97% |
| 4 | Communication Services | 8.68% |
| 5 | Consumer Discretionary | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Civista Bancshares
CIVB
$403M
| $51K | ﹤0.01% |
2,673
+1,700
| +175% | +$32.4K |
|
3452
Equity Bancshares
EQBK
$790M
| $51K | ﹤0.01% |
2,175
+1,503
| +224% | +$35.2K |
|
3453
Generation Bio
GBIO
$39M
| $51K | ﹤0.01% |
190
+133
| +233% | +$35.7K |
|
|
JMIA
3454
Jumia Technologies
JMIA
$1.46B
| $51K | ﹤0.01% |
1,383
-99,104
| -99% | -$3.65M |
|
|
NOA
3455
North American Construction
NOA
$405M
| $51K | ﹤0.01% |
5,138
+3,140
| +157% | +$31.2K |
|
3456
Cartesian Therapeutics
RNAC
$249M
| $51K | ﹤0.01% |
525
+420
| +400% | +$40.8K |
|
3457
Spero Therapeutics
SPRO
$107M
| $51K | ﹤0.01% |
3,184
+2,499
| +365% | +$40K |
|
3458
Vital Energy
VTLE
$639M
| $51K | ﹤0.01% |
2,096
+1,424
| +212% | +$34.6K |
|
|
PRTK
3459
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $51K | ﹤0.01% |
8,215
+4,717
| +135% | +$29.3K |
|
3460
Clearfield
CLFD
$468M
| $50K | ﹤0.01% |
1,924
+1,407
| +272% | +$36.6K |
|
3461
WisdomTree Europe Quality Dividend Growth Fund
EUDG
$80.8M
| $50K | ﹤0.01% |
1,605
| – | – |
|
|
GAU
3462
Galiano Gold
GAU
$623M
| $50K | ﹤0.01% |
42,895
+25,913
| +153% | +$30.2K |
|
3463
BlackRock MuniYield Michigan Quality Fund
MIY
$332M
| $50K | ﹤0.01% |
3,456
+1,177
| +52% | +$17K |
|
3464
Napco Security Technologies
NSSC
$1.51B
| $50K | ﹤0.01% |
3,630
-76,484
| -95% | -$1.05M |
|
3465
NVE Corp
NVEC
$320M
| $50K | ﹤0.01% |
785
+510
| +185% | +$32.5K |
|
3466
Park-Ohio Holdings
PKOH
$317M
| $50K | ﹤0.01% |
1,547
+949
| +159% | +$30.7K |
|
3467
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$847M
| $50K | ﹤0.01% |
+1,421
| New | +$50K |
|
3468
Regis Corp
RGS
$68.4M
| $50K | ﹤0.01% |
301
+216
| +254% | +$35.9K |
|
3469
Invesco S&P 500 Quality ETF
SPHQ
$15.3B
| $50K | ﹤0.01% |
1,175
| – | – |
|
3470
Tejon Ranch
TRC
$440M
| $50K | ﹤0.01% |
3,352
+2,382
| +246% | +$35.5K |
|
|
GATO
3471
DELISTED
Gatos Silver, Inc.
GATO
| $50K | ﹤0.01% |
+3,707
| New | +$50K |
|
|
CHS
3472
DELISTED
Chicos FAS, Inc.
CHS
| $50K | ﹤0.01% |
28,799
+21,670
| +304% | +$37.6K |
|
|
RUBY
3473
DELISTED
Rubius Therapeutics, Inc
RUBY
| $50K | ﹤0.01% |
5,513
+3,851
| +232% | +$34.9K |
|
|
PRVL
3474
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $50K | ﹤0.01% |
2,183
+1,523
| +231% | +$34.9K |
|
3475
Aligos Therapeutics
ALGS
$64.2M
| $49K | ﹤0.01% |
+63
| New | +$49K |
|